Thackray Helen M. 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed May 15, 2024
Insider Transaction Report
Form 4
Thackray Helen M.
Chief R&D Officer
Transactions
- Purchase
Common Stock
2024-05-14$5.86/sh+30,000$175,800→ 272,139 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.84 to $5.86. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.